hypertension-care.eu Report : Visit Site

Technical data of the hypertension-care.eu

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host hypertension-care.eu. Currently, hosted in Germany and its service provider is DomainFactory GmbH .

the related websites

pathways.nice.org.uk lifestyle.walsallhealthcare.nhs.uk bluebirdcare.co.uk angelcare.org.uk careopinion.org.uk carealarms.co.uk core.ac.uk glassdoor.co.uk bhsoc.org derbyshiremedicinesmanagement.nhs.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx/1.8.0 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

this site uses cookies to provide services necessary for the operation. if you want to learn more or opt out of all or some cookies, see the cookie policy . by closing this banner, scrolling this page, clicking on consent or continuing navigation in any other way, you consent to the use of cookies passion for innovation. compassion for patients.™ show side content location finder services adverse event reporting download center daiichi sankyo websites contact find us search print page contact twitter youtube xing linkedin slideshare career esc congress 2018 the world of cardiology gathers in munich who we are daiichi sankyo is a global pharmaceutical company based in japan our commitment to antithrombotics follow us on twitter navigation about us who we are daiichi sankyo in europe european strategy european structure european affiliates european history global history responsibility sustainability green mobility people who live with atrial fibrillation csr in europe little hearts corporate conduct charter patient groups sponsoring transparency integrity alert research & development pipeline antithrombotic agents r&d network tissue and cell research center investments taneds global 2018 investigator-initiated studies products adverse event reporting columbus award for daiichi sankyo europe european products european production sites antithrombotics antithrombotics understanding thrombosis antithrombotic trials oncology daiichi sankyo cancer enterprise adc franchise aml franchise other late-stage programs daiichi sankyo cancer enterprise timeline daiichi sankyo cancer enterprise global pipeline media esc congress 2018 events and congresses european news press contacts subscribe press news unsubscribe press news services adverse event reporting download center career daiichi sankyo websites contact find us search location finder dear user, this website provides you with information only for healthcare professionals. according to the drug promotion code, we are only able to allow healthcare professionals like physicians and pharmacists to have full access to our website. to visit our page please login. daiichi sankyo doc check username: password: password forgotten? register username: password: password forgotten? register help featured stories support for young talents for the last nine years daiichi sankyo has supported young graduates in pharmaceutical sciences from the ludwig-maximilians-university in munich (lmu). in 2017, kristina eiglmeier and martin müller were awarded the "master prize" read more... value report 2017 the new daiichi sankyo group’s value report is now available! the report includes business facts & figures, information about daiichi sankyo’s growth potential, csr activities and much more. read more... featured news date description 28/08/2018 products daiichi sankyo presents first snapshot analyses from global etna-af programme of oral, once-daily lixiana®▼ (edoxaban) in patients with nonvalvular atrial fibrillation in routine clinical practice pdf 01/08/2018 products fda grants breakthrough therapy designation to daiichi sankyo’s flt3 inhibitor quizartinib for relapsed/refractory flt3-itd aml pdf 30/07/2018 research daiichi sankyo enters worldwide licensing agreement with glycotope for gatipotuzumab antibody drug conjugate pdf 16/06/2018 research phase 3 quantum-r study demonstrates daiichi sankyo’s quizartinib significantly prolongs overall survival as single agent compared to chemotherapy in patients with relapsed/refractory aml with flt3-itd mutations pdf 06/06/2018 research daiichi sankyo to present late-breaking phase 3 data for single agent quizartinib in patients with relapsed/refractory aml with flt3-itd mutations at plenary session at eha 2018 pdf show all about us who we are daiichi sankyo in europe european strategy european structure european affiliates european history global history responsibility sustainability green mobility people who live with atrial fibrillation csr in europe little hearts corporate conduct charter patient groups sponsoring transparency integrity alert research & development pipeline antithrombotic agents r&d network tissue and cell research center investments taneds global 2018 investigator-initiated studies products adverse event reporting columbus award for daiichi sankyo europe european products european production sites antithrombotics antithrombotics understanding thrombosis antithrombotic trials oncology daiichi sankyo cancer enterprise adc franchise aml franchise other late-stage programs daiichi sankyo cancer enterprise timeline daiichi sankyo cancer enterprise global pipeline media esc congress 2018 events and congresses european news press contacts subscribe press news unsubscribe press news print page contact twitter youtube xing linkedin slideshare copyright © , all rights reserved. last update: 07.12.2017 disclaimer data protection imprint site map location finder career print page contact twitter youtube xing linkedin slideshare login dear user, this website provides you with information only for healthcare professionals. according to the drug promotion code, we are only able to allow healthcare professionals like physicians and pharmacists to have full access to our website. to visit our page please login. daiichi sankyo doc check username: password: password forgotten? register username: password: password forgotten? register help

URL analysis for hypertension-care.eu

https://www.daiichi-sankyo.eu/index.php?id=340&type=30&tx_linkdisclaimer_pi1%5bredirect%5d=https%253a%252f%252fwww.linkedin.com%252fcompany%252fdaiichi-sankyo-europe-gmbh
https://www.daiichi-sankyo.eu/about-us/responsibility/csr-in-europe/support-for-young-talents/
https://www.daiichi-sankyo.eu/research-development/taneds-global-2018/
https://www.daiichi-sankyo.eu/about-us/responsibility/corporate-conduct-charter/
https://www.daiichi-sankyo.eu/community/register/?no_cache=1
https://www.daiichi-sankyo.eu/services/daiichi-sankyo-websites/
https://www.daiichi-sankyo.eu/services/find-us/
https://www.daiichi-sankyo.eu/community/login/?return_url=%2fmedia%2feuropean-news%2fnews-detail%2fnews%2ffda-grants-breakthrough-therapy-designation-to-daiichi-sankyos-flt3-inhibitor-quizartinib-for-relap%2f%3ftx_news_pi1%255bcontroller%255d%3dnews%26tx_news_pi1%255baction%255d%3ddetail%26chash%3d03b1e5f40470db24b5b9a84a09a9e631&pageid=7422&chash=76c585fe6d9bbb8d4d08743b958b6eeb
https://www.daiichi-sankyo.eu/media/esc-congress-2018/
https://www.daiichi-sankyo.eu/products/european-products/
https://www.daiichi-sankyo.eu/community/login/?return_url=%2fmedia%2feuropean-news%2fnews-detail%2fnews%2fdaiichi-sankyo-presents-first-snapshot-analyses-from-global-etna-af-programme-of-oral-once-daily-li%2f%3ftx_news_pi1%255bcontroller%255d%3dnews%26tx_news_pi1%255baction%255d%3ddetail%26chash%3dc7d7cc1d0287ef5ae3356d2697626b11&pageid=7422&chash=3516d603126372621ee459a01105ab9b
https://www.daiichi-sankyo.eu/about-us/responsibility/sustainability/
https://www.daiichi-sankyo.eu/about-us/responsibility/people-who-live-with-atrial-fibrillation/
https://www.daiichi-sankyo.eu/about-us/who-we-are/
https://www.daiichi-sankyo.eu/index.php?id=340&type=30&tx_linkdisclaimer_pi1%5bredirect%5d=http%253a%252f%252fwww.daiichisankyo.com%252fabout_us%252fwho_we_are%252fhistory%252findex.html

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

% The WHOIS service offered by EURid and the access to the records
% in the EURid WHOIS database are provided for information purposes
% only. It allows persons to check whether a specific domain name
% is still available or not and to obtain information related to
% the registration records of existing domain names.
%
% EURid cannot, under any circumstances, be held liable in case the
% stored information would prove to be wrong, incomplete or not
% accurate in any sense.
%
% By submitting a query you agree not to use the information made
% available to:
%
% - allow, enable or otherwise support the transmission of unsolicited,
% commercial advertising or other solicitations whether via email or
% otherwise;
% - target advertising in any possible way;
%
% - to cause nuisance in any possible way to the registrants by sending
% (whether by automated, electronic processes capable of enabling
% high volumes or other possible means) messages to them.
%
% Without prejudice to the above, it is explicitly forbidden to extract,
% copy and/or use or re-utilise in any form and by any means
% (electronically or not) the whole or a quantitatively or qualitatively
% substantial part of the contents of the WHOIS database without prior
% and explicit permission by EURid, nor in any attempt hereof, to apply
% automated, electronic processes to EURid (or its systems).
%
% You agree that any reproduction and/or transmission of data for
% commercial purposes will always be considered as the extraction of a
% substantial part of the content of the WHOIS database.
%
% By submitting the query you agree to abide by this policy and accept
% that EURid can take measures to limit the use of its WHOIS services
% in order to protect the privacy of its registrants or the integrity
% of the database.
%
% The EURid WHOIS service on port 43 (textual whois) never
% discloses any information concerning the registrant.
% Registrant and onsite contact information can be obtained through use of the
% webbased whois service available from the EURid website www.eurid.eu
%
% WHOIS hypertension-care.eu
Domain: hypertension-care.eu

Registrant:
NOT DISCLOSED!
Visit www.eurid.eu for webbased whois.

Onsite(s):
NOT DISCLOSED!
Visit www.eurid.eu for webbased whois.

Registrar:
Name: EPAG Domainservices GmbH
Website: www.epag.eu

Name servers:
ns2.daiichi-dns.de
ns1.daiichi-dns.de

Please visit www.eurid.eu for more info.

  REFERRER http://www.eurid.eu

  REGISTRAR EURID

SERVERS

  SERVER eu.whois-servers.net

  ARGS hypertension-care.eu

  PORT 43

  TYPE domain

DOMAIN

  NAME hypertension-care.eu

REGISTRAR

  NAME EPAG Domainservices GmbH

  URL www.epag.eu

NSERVER

  NS2.DAIICHI-DNS.DE 212.123.32.78

  NS1.DAIICHI-DNS.DE 212.123.35.78

OWNER
NOT DISCLOSED!
Visit www.eurid.eu for webbased whois.
Onsite(s):
NOT DISCLOSED!
Visit www.eurid.eu for webbased whois.

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .